Vicarious Surgical Inc. (NYSE:RBOT) Sees Large Drop in Short Interest

by · The Markets Daily

Vicarious Surgical Inc. (NYSE:RBOT – Get Free Report) saw a large decrease in short interest in December. As of December 31st, there was short interest totaling 140,432 shares, a decrease of 32.3% from the December 15th total of 207,502 shares. Currently, 2.4% of the shares of the company are sold short. Based on an average daily trading volume, of 110,484 shares, the days-to-cover ratio is presently 1.3 days. Based on an average daily trading volume, of 110,484 shares, the days-to-cover ratio is presently 1.3 days. Currently, 2.4% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of research firms recently weighed in on RBOT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Vicarious Surgical in a research note on Wednesday, October 8th. Wall Street Zen raised Vicarious Surgical from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Finally, BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $7.00.

Check Out Our Latest Stock Analysis on Vicarious Surgical

Vicarious Surgical Stock Down 6.5%

NYSE:RBOT traded down $0.19 during mid-day trading on Friday, hitting $2.68. 79,954 shares of the stock traded hands, compared to its average volume of 175,721. The business’s 50-day moving average price is $2.71 and its 200 day moving average price is $5.56. The company has a market cap of $17.52 million, a PE ratio of -0.30 and a beta of 1.52. Vicarious Surgical has a 12-month low of $1.80 and a 12-month high of $16.92.

Vicarious Surgical (NYSE:RBOT – Get Free Report) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.37) by $0.46. Analysts anticipate that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Vicarious Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Connective Capital Management LLC bought a new position in Vicarious Surgical in the 3rd quarter worth about $169,000. Dimensional Fund Advisors LP boosted its position in shares of Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after acquiring an additional 3,615 shares during the last quarter. Finally, DNB Asset Management AS grew its holdings in shares of Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after purchasing an additional 3,154 shares in the last quarter. 47.27% of the stock is currently owned by hedge funds and other institutional investors.

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.

Featured Stories